SyncThink
SyncThink (legal: NeuroSync Inc.) provides the FDA-cleered [cleared] EYE-SYNC VR-based eye-tracking platform for objective brain health and concussion assessment. It serves healthcare providers, sports organizations, the military, and biopharma customers through enterprise direct sales.
- Company typePrivate
- Founded2009
- HeadquartersPalo Alto, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What SyncThink does
SyncThink, operating under the legal entity NeuroSync Inc. and headquartered in Palo Alto, California, is a private digital health company that has built the FDA-cleared EYE-SYNC platform — a wireless VR-based system that objectively measures eye movements to assess brain health, detect concussions, and support clinical decision-making. The platform combines proprietary XR hardware, AI-powered analytics, and customizable reports, with each assessment reportedly completed in under one minute and validated at a 0.9 test-retest reliability. Independent research validation of the underlying quantification methods is highlighted on the company's marketing materials.
The company sells to four primary verticals: Healthcare Providers (hospitals and specialty clinics for concussion assessment, vestibular therapy, and brain health diagnostics), Sports Organizations (university and professional athletic programs for athlete safety), Military (active duty cognitive performance optimization), and Biopharma (CNS clinical trial endpoints and drug response monitoring). Named customers include Massachusetts General Hospital, Houston Methodist, Sutter Health, St. David's Medical Center, Rice University, Georgia Tech, and Virginia Tech, alongside specialty clinics such as the Kutcher Clinic for Sports Neurology and the Kaizen Brain Center.
The business model is enterprise B2B direct sales with a "Request a Demo" engagement motion, monetizing through bundled VR hardware and proprietary software/analytics sales. Pricing is not publicly disclosed, consistent with a consultative sales approach targeting larger institutional contracts. The company was founded in 2009, remains private, and operates with a 1–10 employee team, with disclosed funding of approximately $3.6 million across rounds from Quadrant Management, Oceanic Partners, MassChallenge, and StartUp Health, the most recent dated 2019.
SyncThink firmographics
Firmographics- Name
- SyncThink
- Legal name
- NeuroSync Inc.
- Website
- https://syncthink.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- SyncThink (legal: NeuroSync Inc.) provides the FDA-cleered [cleared] EYE-SYNC VR-based eye-tracking platform for objective brain health and concussion assessment. It serves healthcare providers, sports organizations, the military, and biopharma customers through enterprise direct sales.
- Ownership category
- akta.pro rank
SyncThink industry classification
Industry- Product category
- Digital Health Neurotechnology
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Industrial Instruments For Measurement, Display, And Control (3823), Computer Peripheral Equipment, Nec (3577)
- akta.pro primary industry
- Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)
- akta.pro secondary industries
- Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Smart Fitness & Training Devices (Connected Fitness Sensors, Smart Jump Ropes, etc.) (CRACAQAH), VR/XR Hardware & Accessories (Headsets, Controllers, Trackers, Haptics) (MPAFAGAG)
Keywords
Where SyncThink is headquartered
LocationHeadquarters
- HQ city
- Palo Alto
- HQ country
- United States
- HQ region
- North America
Markets served
SyncThink business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Supply Chain
Revenue model
- VR Platform and Software Sales: Sale of VR hardware (XR hardware) combined with proprietary software and analytics. The platform is customized for various use cases including healthcare, sports, military, and biopharma applications.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
SyncThink product offering
Product offeringCore offering
SyncThink sells the EYE-SYNC platform, an FDA-cleared, VR-based eye-tracking assessment system that objectively measures eye movements to evaluate brain health, diagnose concussions, and support clinical and performance decision-making. The offering bundles wireless XR hardware with proprietary AI-powered software and analytics and customizable reports, delivered as enterprise solutions for healthcare providers, sports organizations, the military, and biopharma companies. Assessments complete in under one minute with 0.9 test-retest reliability.
Product overview
NeuroSync offers a digital health platform for assessing brain health and optimizing performance. The core product is EYE-SYNC, an FDA-cleared VR-based system that objectively measures eye movements to detect neurological deficits and support clinical decision-making. The platform consists of wireless XR Hardware, Software & Analytics powered by AI, and Customizable Reports. The product portfolio includes Neuro Health for healthcare and clinical research applications, and Brain Performance for sports, military, and high-performance optimization use cases. All assessments are completed in under a minute with validated metrics showing 0.9 test-retest reliability.
Differentiator
Problem solved
Functional benefit
Brands
- EYE-SYNC: FDA-cleared VR-based eye tracking assessment platform for concussion diagnosis and brain health monitoring
Products and services
- EYE-SYNC FDA-cleared VR-based assessment platform that objectively measures eye movements to evaluate brain health, detect concussions, and support clinical decision-making. The system uses proprietary algorithms and quantification methods validated in independent research, with assessments completed in under one minute and 0.9 test-retest reliability. Targeted at healthcare providers, sports programs, military, and biopharma researchers.
- Neuro Health Brain health assessment solution designed for healthcare providers to support advanced patient care and clinical research, enabling objective diagnostics for neurological conditions. Targeted at hospitals, clinics, and academic medical centers running neurology and sports neurology practices.
- Brain Performance Performance optimization solution for sports organizations, military, and high-performance specialists to assess and optimize brain function and decision-making capabilities. Targeted at universities, professional sports teams, and defense organizations.
Quantifiable outcome
- 0.9 test-retest reliability for all assessments
- +1 more outcomes
Companies that use SyncThink
Customer profileNamed customers10 records
Segments4 records
Ideal customer profiles4 records
SyncThink technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature3 records
SyncThink partnerships and signals
Strategic signalScale indicators2 records
Recent moves6 records
Expansion highlights5 records
SyncThink competitors and assessment
Company assessmentDirect peers
- Oculogica: Oculogica develops FDA-cleared eye-tracking-based concussion and brain injury assessment tools that compete directly with SyncThink's EYE-SYNC platform. Both target the same clinical and sports customer base with VR-style eye-movement analytics.
- ImPACT Applications: ImPACT Applications is the dominant FDA-cleared computerized concussion assessment tool used across collegiate and professional sports. It competes with SyncThink in concussion management for schools, sports organizations, and military.
- BrainScope: BrainScope offers FDA-cleared EEG-based brain injury assessment devices used in hospital and military settings. It overlaps with SyncThink's clinical and military verticals as an objective brain-diagnostic alternative.
- King-Devick Technologies: King-Devick provides an eye-movement-based sideline concussion screening test used widely in sports. It targets the same athlete safety and concussion-management use case as SyncThink's Brain Performance module.
- Sway Medical: Sway Medical delivers mobile balance and reaction-time-based concussion assessment apps used by athletic programs. It competes for the same sports and university concussion-management budget as SyncThink.
Emerging players
- Mindstrong: Mindstrong developed digital biomarkers for neuropsychiatric conditions using smartphone-based interactions, an emerging alternative to clinic-visit brain health assessment. It overlaps with SyncThink's objective-neuroassessment positioning.
- Altoida: Altoida provides FDA Breakthrough-designated digital cognitive assessment tools using smartphone AR for neurodegenerative disease detection. It competes in the broader neurological-assessment category with SyncThink.
- C3 Logix: C3 Logix offers a multi-modal concussion assessment tablet platform used by schools and sports programs, overlapping with SyncThink's sports and education verticals.
Broad incumbents
- Akili Interactive: Akili Interactive delivers FDA-cleared digital therapeutics (EndeavorRx) for cognitive conditions, operating in the same digital-neurohealth category as SyncThink. Both pursue FDA-cleared digital solutions for brain health.
Others
- Tobii: Tobii is a global leader in eye-tracking technology and hardware, named as a partner/technology logo for NeuroSync. It is an enabling technology supplier to SyncThink's EYE-SYNC platform rather than a competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
SyncThink social profiles
Digital presenceSyncThink compliance and trust
Trust signalCompliance1 record
SyncThink financial estimates
Financial estimateRevenue estimate
Valuation estimate
SyncThink leadership team
Management profileNumber of profiles
Profiles4 records
SyncThink funding detail
Funding detailFunding overview
Funding rounds4 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SyncThink M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SyncThink
What does SyncThink do?
SyncThink sells the EYE-SYNC platform, an FDA-cleared, VR-based eye-tracking assessment system that objectively measures eye movements to evaluate brain health, diagnose concussions, and support clinical and performance decision-making. The offering bundles wireless XR hardware with proprietary AI-powered software and analytics and customizable reports, delivered as enterprise solutions for healthcare providers, sports organizations, the military, and biopharma companies. Assessments complete in under one minute with 0.9 test-retest reliability.
Is SyncThink a public or private company?
SyncThink is a private company. It is classified as venture growth investor backed and is currently operating.
When was SyncThink founded?
SyncThink was founded in 2009. It employs 1 to 10 people.
Where is SyncThink based?
SyncThink is headquartered in Palo Alto, United States, in the North America region.
How does SyncThink make money?
One revenue line is on record: VR Platform and Software Sales.
Who are SyncThink's main competitors?
Direct peers on record are Oculogica, ImPACT Applications, BrainScope, King-Devick Technologies and Sway Medical. Emerging players are Mindstrong, Altoida and C3 Logix. Akili Interactive is listed as a broad incumbent. Tobii is listed as an others.
Does SyncThink have an API?
No public API is recorded for SyncThink.
What industry is SyncThink in?
SyncThink's product category is Digital Health Neurotechnology. Its primary akta.pro industry code is HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables), with a secondary code of HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 334510 and its SIC code is 3845.